Guardant Health
GH
#1166
Rank
NZ$35.29 B
Marketcap
NZ$260.93
Share price
-0.52%
Change (1 day)
52.93%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report